ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH
10.1002/ptr.1662 Phytother Res
Associated Conditions (rare, long-term risk) Certain lymphomas such as Burkitt lymphoma or Hodgkin lymphoma Nasopharyngeal carcinoma Post-transplant lymphoproliferative disease Possible links with multiple sclerosis and chronic fatigue syndrome (still under study) Diagnosis Blood tests (serologies like VCA IgM, VCA IgG, EBNA IgG) help determine if the infection is acute, past, or reactivated
No published study has linked it to tumor promotion, but if you have an active malignancy, the theoretical risk of feeding blood vessels to a tumor is worth taking seriously
Another common comparison is glutathione IV therapy versus oral glutathione supplements
Goal-Specific Dosing Considerations The optimal MOTS-c dose is not one-size-fits-all: it shifts depending on whether the clinical goal is metabolic correction, athletic performance enhancement, or anti-aging and longevity support